Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01156415
Recruitment Status : Terminated
First Posted : July 2, 2010
Last Update Posted : March 14, 2013
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 2011
Actual Study Completion Date : October 2011
Certification/Extension First Submitted : February 14, 2013